Breilh, Dominique <br/><br/>
Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Nov 2009 
 - 428-30 p.  digital 
<br/><br/> Publication Type: Letter; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1944-7884 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0b013e3181b62858  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--pharmacokinetics<br/>Female<br/>HIV Infections--complications<br/>Hepacivirus<br/>Hepatitis C--complications<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Male<br/>Polyethylene Glycols--therapeutic use<br/>RNA, Viral--blood<br/>Recombinant Proteins<br/>Ribavirin--blood